Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    January 2019

  1. Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-300.
    PubMed     Text format    


  2. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380:171-176.
    PubMed     Text format    


  3. VERMA S, Mazer CD
    Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
    N Engl J Med. 2019;380:189-191.
    PubMed     Text format    


    December 2018
  4. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    PubMed     Text format    


  5. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    PubMed     Text format    


    November 2018
  6. BURNETT JR, Hooper AJ
    PCSK9 - A Journey to Cardiovascular Outcomes.
    N Engl J Med. 2018;379:2161-2162.
    PubMed     Text format    


  7. KOPJAR T, Gasparovic H, Biocina B
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-7.
    PubMed     Text format    


  8. REHMAN SM, Duggan SMJ
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed     Text format    


  9. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed     Text format    



  10. Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-1968.
    PubMed     Text format    


  11. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
    Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
    PubMed     Text format     Abstract available


  12. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
    PubMed     Text format     Abstract available


  13. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
    PubMed     Text format     Abstract available


  14. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    PubMed     Text format     Abstract available


  15. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    PubMed     Text format     Abstract available


  16. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    PubMed     Text format     Abstract available


  17. ADRIAENSSENS T, Van de Werf F
    Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
    N Engl J Med. 2018;379:1775-1776.
    PubMed     Text format    


  18. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2018;379:1699-1710.
    PubMed     Text format     Abstract available


    October 2018

  19. Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582-1584.
    PubMed     Text format    


  20. MONTENEGRO MF, Lundberg JO, Weitzberg E
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583-4.
    PubMed     Text format    


  21. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583.
    PubMed     Text format    


  22. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582.
    PubMed     Text format    


  23. DRAZEN JM
    Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
    N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
    PubMed     Text format    



  24. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2018;379:1486.
    PubMed     Text format    



  25. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-1389.
    PubMed     Text format    


  26. STEWART RAH
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1388.
    PubMed     Text format    


  27. JENKINS D, Sievenpiper J, Jones P
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-8.
    PubMed     Text format    


  28. CORREIA LCL
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387.
    PubMed     Text format    


    September 2018
  29. FIELD ME, Page RL
    Another Shock for Sudden Death Prevention after Myocardial Infarction.
    N Engl J Med. 2018;379:1274-1275.
    PubMed     Text format    


  30. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2018;379:1205-1215.
    PubMed     Text format     Abstract available


  31. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
    PubMed     Text format     Abstract available


    August 2018
  32. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available


  33. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Text format     Abstract available


  34. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Text format     Abstract available



  35. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    PubMed     Text format     Abstract available


  36. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    PubMed     Text format    


  37. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Text format     Abstract available


  38. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    PubMed     Text format    


    July 2018
  39. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
    Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med. 2018;379:250-259.
    PubMed     Text format     Abstract available


    June 2018
  40. CUERVO G, Viasus D, Carratala J
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2540.
    PubMed     Text format    


  41. BUCKLEY LF
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539-40.
    PubMed     Text format    


  42. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed     Text format    


  43. WIESSMAN M, Shlomai A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed     Text format    


  44. WAXMAN DA, Kanzaria HK, Schriger DL
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-9.
    PubMed     Text format    



  45. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-2541.
    PubMed     Text format    


  46. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    PubMed     Text format    


  47. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    PubMed     Text format     Abstract available


  48. ARBOINE L, Palacios JM
    Left Main Coronary Artery Aneurysm.
    N Engl J Med. 2018;378:e32.
    PubMed     Text format    


    May 2018
  49. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    PubMed     Text format    


  50. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Text format     Abstract available


    April 2018
  51. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    PubMed     Text format     Abstract available


  52. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Text format     Abstract available


  53. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed     Text format    


  54. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    PubMed     Text format    


  55. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    PubMed     Text format    


  56. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    PubMed     Text format    


  57. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    PubMed     Text format    


  58. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    PubMed     Text format    


  59. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    PubMed     Text format    


  60. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    PubMed     Text format    



  61. PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    PubMed     Text format    


    March 2018
  62. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    PubMed     Text format    


  63. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    PubMed     Text format     Abstract available


  64. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    PubMed     Text format    


    February 2018

  65. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    PubMed     Text format    


    January 2018
  66. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed     Text format    


  67. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    PubMed     Text format     Abstract available


  68. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed     Text format    


  69. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed     Text format    


  70. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    PubMed     Text format    


  71. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    PubMed     Text format    



  72. Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    PubMed     Text format    


  73. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed     Text format    


  74. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed     Text format    


  75. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed     Text format    


  76. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed     Text format    


  77. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed     Text format    



  78. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    PubMed     Text format    


  79. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    PubMed     Text format    



  80. Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    PubMed     Text format    


  81. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    PubMed     Text format    


  82. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    PubMed     Text format    


  83. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    PubMed     Text format    


    December 2017
  84. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed     Text format    


  85. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed     Text format    


  86. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    PubMed     Text format    


  87. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed     Text format    


    November 2017

  88. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    PubMed     Text format    


  89. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    PubMed     Text format    


  90. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    PubMed     Text format    


  91. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    PubMed     Text format    


  92. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed     Text format    


  93. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Text format     Abstract available


  94. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    PubMed     Text format    


  95. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    PubMed     Text format    


  96. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    PubMed     Text format    


  97. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    PubMed     Text format    



  98. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    PubMed     Text format    


    October 2017
  99. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    PubMed     Text format     Abstract available


  100. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    PubMed     Text format    


  101. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    PubMed     Text format    


  102. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    PubMed     Text format    


  103. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    PubMed     Text format    


  104. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    PubMed     Text format    



  105. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    PubMed     Text format    


    September 2017
  106. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    PubMed     Text format     Abstract available


  107. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Text format     Abstract available


  108. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: